Literature DB >> 25383737

Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.

Markus R Meyer1, Andreas G Helfer, Hans H Maurer.   

Abstract

This paper reviews high-resolution MS approaches published from January 2011 until March 2014 for the quantification of drugs (of abuse) and/or their metabolites in biosamples using LC-MS with time-of-flight or Orbitrap™ mass analyzers. Corresponding approaches are discussed including sample preparation and mass spectral settings. The advantages and limitations of high-resolution MS for drug quantification, as well as the demand for a certain resolution or a specific mass accuracy are also explored.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25383737     DOI: 10.4155/bio.14.164

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  3 in total

1.  Proposed Confidence Scale and ID Score in the Identification of Known-Unknown Compounds Using High Resolution MS Data.

Authors:  Bertrand Rochat
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-23       Impact factor: 3.109

2.  Medication contaminants as a potential cause of anaphylaxis to vincristine.

Authors:  David A Hill; Allison Barz Leahy; Joseph Sciasci; Sean P O'Neill; Anne Reilly; Naomi Balamuth; Steven H Seeholzer; Jonathan M Spergel; Terri F Brown-Whitehorn
Journal:  Pediatr Blood Cancer       Date:  2017-08-22       Impact factor: 3.167

3.  Triple Quadrupole Versus High Resolution Quadrupole-Time-of-Flight Mass Spectrometry for Quantitative LC-MS/MS Analysis of 25-Hydroxyvitamin D in Human Serum.

Authors:  Timon Geib; Lekha Sleno; Rabea A Hall; Caroline S Stokes; Dietrich A Volmer
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-06       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.